CXN Clinical has been involved in managing and implementing clinical trials for more than 20 years across many therapeutic areas, including:

  • Oncology: Breast, Lung, Melanoma, Prostate, Hematologic (Phase I/II, III)
  • Dermatology: Injectables and topicals, Wound healing, Surgical scars, Acne, Skin irritation (Phase I, II)
  • Respiratory: Asthma, Allergic Rhinitis, Sinusitis (Phase II, III)
  • CNS: Pain management (in-patient setting), Lower back pain, Spinal metastasis,
  • Anesthesia/sedation (Phase I, II, III)
  • Cardiovascular: Hypertension, Angina (Phase II, III)
  • Gastroenterology: Gastric ulcer, Non-ulcer dyspepsia (Phase III)
  • Gynecology: Candidiasis (Phase III)
  • Infectious Disease: Sepsis, Sinus infection (Phase II, III)
  • Orthopedic: Knee replacement, Hip replacement (Phase II, III)
  • Ophthalmology: Vitreous hemorrhage (Phase III)